Citigroup initiates coverage on Ryan Specialty with a Buy rating and $74 PT.
ByAinvest
Wednesday, Aug 13, 2025 8:03 am ET1min read
C--
Ryan Specialty reported its second-quarter results, with net sales increasing by 10.2% to $1.2 billion, up from $1.1 billion in the same period last year. The company's shares have been trading higher since, with a 5.6% increase to $63.75 at last check on Friday.
Goldman Sachs analyst Bonnie Herzog reiterated her Buy rating on Ryan Specialty, raising the price forecast from $70 to $73. Herzog highlighted the company's strong topline growth, driven by innovative product offerings and the potential for share gains from new product lines. Despite concerns over rising ingredient costs, Ryan Specialty outperformed expectations.
Citi analyst Filippo Falorni echoed these sentiments, noting the company's robust pipeline, which includes new snack and beverage lines. These innovations are expected to sustain healthy topline growth and navigate challenging year-over-year comparisons in the coming years.
Ryan Specialty's valuation remains attractive, trading at a ~48% forward P/E premium to its peers, below its three-year average of ~50%. The company's faster volume-driven growth profile further supports its valuation.
Following the second-quarter EPS beat, Goldman Sachs has raised its fiscal year 2025 and fiscal year 2026 EPS estimates by $0.02 to $1.80 and $2.05, respectively.
References:
[1] https://finance.yahoo.com/news/monster-beverage-leverages-functional-zero-170306634.html
[2] https://www.tipranks.com/news/the-fly/monster-beverage-price-target-raised-to-74-from-70-at-citi-thefly?mod=mw_quote_news
RYAN--
Citigroup initiates coverage on Ryan Specialty with a Buy rating and $74 PT.
Citigroup has initiated coverage on Ryan Specialty Brands, Inc. (RYSB) with a Buy rating and a price target of $74. The investment bank highlights the company's robust pipeline and strong market position in the specialty food and beverage sector.Ryan Specialty reported its second-quarter results, with net sales increasing by 10.2% to $1.2 billion, up from $1.1 billion in the same period last year. The company's shares have been trading higher since, with a 5.6% increase to $63.75 at last check on Friday.
Goldman Sachs analyst Bonnie Herzog reiterated her Buy rating on Ryan Specialty, raising the price forecast from $70 to $73. Herzog highlighted the company's strong topline growth, driven by innovative product offerings and the potential for share gains from new product lines. Despite concerns over rising ingredient costs, Ryan Specialty outperformed expectations.
Citi analyst Filippo Falorni echoed these sentiments, noting the company's robust pipeline, which includes new snack and beverage lines. These innovations are expected to sustain healthy topline growth and navigate challenging year-over-year comparisons in the coming years.
Ryan Specialty's valuation remains attractive, trading at a ~48% forward P/E premium to its peers, below its three-year average of ~50%. The company's faster volume-driven growth profile further supports its valuation.
Following the second-quarter EPS beat, Goldman Sachs has raised its fiscal year 2025 and fiscal year 2026 EPS estimates by $0.02 to $1.80 and $2.05, respectively.
References:
[1] https://finance.yahoo.com/news/monster-beverage-leverages-functional-zero-170306634.html
[2] https://www.tipranks.com/news/the-fly/monster-beverage-price-target-raised-to-74-from-70-at-citi-thefly?mod=mw_quote_news

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet